Form 4 · Filed Jun 3, 2026, 09:03 PM UTC
ADCT/ADC Therapeutics SA
Azelby Robert — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | F | other | 12,600 | $3 | $38,808 | 112,805 |
| Jun 1, 2026 | A | other | 45,000 | $0 | — | 125,405 |
Source: SEC EDGAR raw filing ↗ · Accession 0001628280-26-040493